ANNOUNCEMENT 23 Apr 2015

On April 23, 2015, the National Treasury created for South African pharmaceutical companies tax incentives regarding R&D expenditures.

NUMBER OF INTERVENTIONS

1

  • 1 harmful
  • 0 neutral
  • 0 liberalising

SOURCE

Government Gazette of the Republic of South Africa,
http://www.gov.za/sites/www.gov.za/files/38732_rg10419_gon346.pdf

Inception date: 23 Apr 2015 | Removal date: open ended

Tax or social insurance relief

On April 23, 2015, the South African National Treasury published under Government Gazette No. 38732 a new tax incentive for pharmaceutical companies performing R&D or clinical trials within South Africa's borders. Such tax deductions may amount to up to 150% of the cost of the R&D operations (amounts above 100% allow to offset future taxable income).

This law comes in the form of an amendment to South Africa's Income Tax Act of 1962 in where it allowed other companies performing R&D operations in South Africa to receive up to 150% of deductions in taxes. Such projects must be preapproved by South Africa's Department of Science and Technology.

AFFECTED SECTORS

 

AFFECTED PRODUCTS

 
N/A